483 Astellas Pharma Tech Mar 2019

483 Astellas Pharma Tech Mar 2019

Jose Cruz Gonzalez FDA$119.00 - Available Now

FDA investigators audited the Astellas Pharma Tech - Takaoka, Japan facility and issued inspectional observations (via FDA 483) on 05 Mar 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 05 Mar 2019
  • Location: Takaoka, Japan
  • FEI: 3002807001
Add To Cart